Abstract:Objective Global brain atrophy was reported as an important structural change in Alzheimer's disease (AD), while it has been detected in the older person with normal cognitive function. Therefore, this study was aimed at investigating the difference of the neural metabolites in the left hippocampus (HIP) and left frontal cortex (FC) among patients who showed global brain atrophy but with different cognitive function. Methods The 33 patients with global brain atrophy confirmed by MRI scan, underwent a comprehensively clinical and neuropsychological assessment including mini-mental state examination (MMSE), activities of daily living scale (ADL) and clock drawing test(CDT). According to the diagnostic and statistical manual of mental disorders, fourth edition(DSM-Ⅳ) and Mayo clinic rochester(MCR), 14 patients were diagnosed as AD, 9 patients as amnestic mild cognitive impairment(aMCI), and 10 patients as normal cognition. Every person was taken a cerebral proton magnetic resonance spectroscopy(1H-MRS) scan to measure the levels of n-acetylaspartate(NAA), choline(Cho), myo-inositol(MI) and Creatine(Cr) in the left HIP and the left FC. Results While compared with the group with normal cognition, the ratio of NAA/Cr in the AD group reduced 10.2% in the left HIP and 5.3% in the left FC, and the ratio of Cho/Cr increased 17.5% in the left HIP and 16.7% in the left FC, and the ratio of MI/Cr increased 39.5% in the left HIP and 19.2% in the left FC. The ratio of NAA/Cr of the left HIP in the AD group was lower than that in the aMCI group at the decrease rate of 6.4%, while the ratio of NAA/Cr of the left FC was not significantly different between the two groups. The AD group had higher ratios of Cho/Cr at the increase rate of 9.3% in the HIP and 12.3% in the FC, and higher MI/Cr ratios at the increase rate of 30% in the HIP and 17% in the FC than in the aMCI group. The aMCI group showed significantly lower ratio of NAA/Cr at the decrease rate of 4.1% and higher ratio of Cho/Cr at the increase rate of 7.5% in the left HIP than in the normal cognition group. Conclusions Among patients with global brain atrophy, the decrement of ratio of NAA/Cr in the left HIP and the increment of the ratio of Cho/Cr and MI/Cr are predictive of the progress from aMCI to AD. Moreover, the decrement of ratio of NAA/Cr in the left HIP and the increment of the ratio of Cho/Cr are helpful to distinguish the aMCI and the persons with normal cognition.

[Application of Multi-Voxel Proton Magnetic Resonance Spectroscopy in Different Hippocampal Regions of Normal Cognitive People].

A proton magnetic resonance spectroscopy imaging study on prefrontal lobe and hippocampus in patients with adolescence-onset schizophrenia

A 1H Magnetic Resonance Spectroscopy Imaging Study on Prefrontal and Hippocampus in Patients with Depression

Correlation of neurochemical metabolism with memory function in young adult patients with first-episode depression studied with proton magnetic resonance spectroscopy]

A Proton Magnetic Resonance Spectroscopy Research on Hippocampus in Patients with Treatment-Resistant Depression

The study of multivoxel 1 H-MRS in detection of different hippocampal regions of Alzheimer’s disease

In vivo study of lipid metabolite in human brain with proton magnetic resonance spectroscopy

A Proton Magnetic Spectroscopy Research on Hippocampus in Suicide-Attempted Depression

A proton magnetic resonance spectroscopy imaging study on prefrontal lobe and hippocampus in male patients with first-episode mania

[A Proton Magnetic Spectroscopy Research on Hippocampus Metabolisms in People with Suicide-Attempted Depressions].

Metabolite Variations in the Hippocampus and Corpus Callosum of Patients with Mild Cognitive Impairment Using Magnetic Resonance Spectroscopy with Three-Dimensional Chemical Shift Images

Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study

Metabolic Changes in Patients with Alzheimer's Disease Assessed by High Field Proton Magnetic Resonance Spectroscopy

Study on biochemical metabolism of brain tissues by proton magnetic resonance spectroscopy in Alzheimer patients

Hippocampal region metabolites and cognitive impairment in patients with general paresis: based on 1H-proton magnetic resonance spectroscopy

The analysis of the neural metabolites in patients with global brain atrophy and different cognitive function in hippocampus and frontal cortex

Longitudinal follow-up of asymmetric changes by proton magnetic resonance spectroscopy in first-episode schizophrenia patients

A quantitative analysis of 1H-MR spectroscopy at 3.0 T of three brain regions from childhood to middle age

The study of hippocampal metabolites level and volumetric changes in AD

Linear Measurements of Healthy Adults’ Coronal Section of Hippocampus on Brain Magnetic Resonance Imaging

Using Proton Magnetic Resonance Spectroscopy to Identify Mild Cognitive Impairment.